Cagrilintide + Semaglutide (Cagri-Sema)

This research combination contains cagrilintide, an amylin-receptor agonist analogue, and semaglutide, a GLP-1-receptor agonist analogue. Laboratory work may examine the two receptor systems and their downstream signaling independently or in combination. For laboratory research and analytical use only. Not intended for human or veterinary use, diagnosis, treatment, prevention, mitigation, or cure of any disease. No therapeutic or performance claims are made. Researchers are responsible for appropriate handling, institutional review, and compliance with all applicable laws and regulations.